on 27th, during Rising Biotech Stars Session (from 14.00 to 16.00)
Company Profile
Obvislim Ltd. is an Israeli Bio-medical startup developing technology that will allow the obese to eat almost whatever they want. The majority of obesity treatments limit the amount/sorts of food consumed by obese patients. This is wrong on a fundamental level, mainly because eating is so much fun. Our Team including physicians and engineers currently is in the POC level and we are searching for seed funding. Our vision is to free obese patients to enjoy food exactly as the non-obese do
Virility Medical is a clinical stage venture, engaged in the development and commercialization of treatment for premature ejaculation by method of neuromodulation. Virility’s product is an intimate perineal skin patch. The patch carries an electronic module that delivers transcutaneous neuromuscular electrical stimulation to the adjacent nerves and muscles. Thus, the muscles are electrically inhibited and, the premature initiation of the ejaculation phase is delayed for the duration of stimulation, after which the patch is disposed of.
RetiCare IVS – Setting the sight on new treatments for retinal diseases
RetiCare is a Danish biotech start-up company focusing on developing new neuroprotective treatments for eye disorders. The company has established in-house a highly translational animal model with end-points that are similar to the diagnostic tool applied in human clinical ophthalmology.
The primary focus is on continuing the development of a new peptide treatment with a novel target discovered and characterized by RetiCare’s founders, which induces neuroprotective effects in the retina. The translational setup will also be used to insource and screen new projects with other targets.
Based on existing data and clinical development feasibility the selected initial indication is retinal detachment, but the indication can upon proof-of concept be expanded to include other indications with involvement death of retinal cells such as glaucoma, age-related macula degeneration, diabetic macular edema, and others.
The team behind RetiCare has in combination several decades of experiences within ophthalmological diseases, neuroprotective effects, clinical practice, and life-science entrepreneurship.
Responsive Web Design powered by 